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ABSTRACT
Introduction: There is a growing proportion of
population aged 65 years and older in low-income and
middle-income countries. In Malaysia, this proportion
is predicted to increase from 5.1% in 2010 to more
than 15.4% by 2050. Cognitive ageing and dementia
are global health priorities. However, risk factors and
disease associations in a multiethnic, middle-income
country like Malaysia may not be consistent with those
reported in other world regions. Knowing the burden
of cognitive impairment and its risk factors in Malaysia
is necessary for the development of management
strategies and would provide valuable information for
other transitional economies.
Methods and analysis: This is a community-based
feasibility study focused on the assessment of
cognition, embedded in the longitudinal study of health
and demographic surveillance site of the South East
Asia Community Observatory (SEACO), in Malaysia. In
total, 200 adults aged ≥50 years are selected for an in-
depth health and cognitive assessment including the
Mini Mental State Examination, the Montreal Cognitive
Assessment, blood pressure, anthropometry, gait
speed, hand grip strength, Depression Anxiety Stress
Score and dried blood spots.
Discussion and conclusions: The results will
inform the feasibility, response rates and operational
challenges for establishing an ageing study focused on
cognitive function in similar middle-income country
settings. Knowing the burden of cognitive impairment
and dementia and risk factors for disease will inform
local health priorities and management, and place
these within the context of increasing life expectancy.
Ethics and dissemination: The study protocol is
approved by the Monash University Human Research
Ethics Committee. Informed consent is obtained from
all the participants. The project’s analysed data and
findings will be made available through publications
and conference presentations and a data sharing
archive. Reports on key findings will be made available
as community briefs on the SEACO website.
INTRODUCTION
Cognitive ageing and dementia are global
public health priorities. The number of
people living with dementia globally is pre-
dicted to increase from 46.8 million in 2015
to 74.7 million in 2030 and 131.5 million in
2050; and more than 70% of them will be
from the low-income and middle-income
countries.1 Malaysia is undergoing a rapid
demographic transition. It is projected that,
by 2050 the older aged population, defined
as persons aged 65 years and older, will make
up 15% of the country’s population.2 This
change in age structure will lead to an
unprecedented increase in the number of
people living with cognitive impairment and
dementia and will have significant personal,
financial and social impacts.
Malaysia is a multiethnic country with wide
cultural diversity.3 Also, it is a very fast
growing and transitional economy. Indeed,
by 2020 it is projected that Malaysia will tran-
sition to a high-income country. Owing to
these reasons, the prevalence and risk factors
of dementia and cognitive impairment may
not be consistent with those reported in
other world regions.
The prevalence estimates of dementia in
developed countries range from 4.7% to
7.2%.4 Few prevalence studies of dementia
and cognitive impairment have been con-
ducted in Malaysia and most have been
undertaken in small non-representative
samples (table 1). No research has been con-
ducted on incidence. Where assessed, the
prevalence of cognitive impairment and
dementia, typically defined using Mini
Mental State Examination (MMSE) cut-off
scores or the Elderly Cognitive Assessment
Mohan D, et al. BMJ Open 2017;7:e013635. doi:10.1136/bmjopen-2016-013635 1
Open Access Protocol
group.bmj.com on April 18, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
Table 1 Summary of findings from prevalence studies of dementia and cognitive impairment in Malaysia
First author
(year) Sample N Age Neuropsychological assessment Results
Krishnaswamy
(1997)5
3 urban settlements in
Kuala Lumpur. No
response rate given
Only Ethnic Malays were
tested
522 ≥60 2-stage screening. ECAQ (cut-off
score≤6) used for further testing
using GSM for an AGECAT
diagnosis of dementia according to
ICD-10 (in Kampung Baru only,
N=400). Neurologist re-examined
dementia patients a 3 months
6% dementia in people
aged ≥65 and 12% in
people aged ≥75
(sample size=323).
Sherina (2004)6 Rural community of a
village of Selangor state.
84.8% response rate
223 ≥60 ECAQ (cut-off score ≤5) 22.4% cognitively
impaired
Rashid (2006)7 2 coastal villages in Kuala
Muda in Kedah. No
response rate given
92 ≥60 ECAQ (cut-off score ≤4) 18.5% cognitive
impairment
Al-Jawad
(2007)8
200-bed Government run
residential home, Malaysia.
83.5% response rate
167 ≥60 ECAQ (cut-off score ≤4, reflecting
probable dementia)
36.5% dementia
Khaw (2009)9 190-bed privately run care
home, Penang Malaysia.
81.6% response rate
155 ≥60 ECAQ (cut-off score ≤5) 12.3% dementia
Norlaily
(2009)10
Outpatient clinics of
University Sains Malaysia
Hospital (HUSM), east
coast of Peninsular
Malaysia 0.100% response
rate phase 1 and 83%
phase 2 (N=39/47)
399 ≥65 2-stage screening. Literate: MMSE
(cut-off ≤17) and illiterate: ECAQ
(cut-off ≤5). All impaired had a
clinical interview based on DSM IV
criteria
2.5% dementia
Hamid (2010)11 National, including all 13
Malaysian states and the
Federal Territory of Kuala
Lumpur. All community
dwelling. 88% response
rate
2980 ≥60 GMS-B3 (AGECAT diagnosis of
dementia)
14.3% dementia
Rashid (2012)12 22 villages from Kedah, a
north western state in
Malaysia. 97.7% response
rate
418 ≥60 ECAQ (cut-off score ≤4, reflecting
probable dementia)
11% cognitively impaired
Razali (2012)13 Anteeds of the Medical and
Nephrology Clinics at
UKMMC. Response rate
96.9%
346 ≥60 MMSE (MCI defined as impairment
on delayed recall of verbal material,
non-verbal material, or both, from
the MMSE, with a total score of 21–
28/30 on the MMSE)
64.7% MCI. 3.1% had
MMSE≤20
Arabi (2013)14 2 primary care clinic in
Cheras, Kuala Lumpur.
96.7% response rate
155 ≥60 EDQ, MMSE≤21 Prevalence of early
dementia using the EDQ
was 52.3%, and
prevalence of dementia
using MMSE was
15.3%.
Pu’un (2014)15 Melanau population in
Mikah (8 out of 32 villages),
an indigenous population in
Sarawak. 28% of elderly
population screened
344 ≥60 Two-stage screening. ECQA
(cut-off score ≤5, reflecting
probable dementia) further
evaluation by clinical interview
(using DSM-IV-TR criteria for
dementia)
27.3% cognitive
impairment and 10.5%
dementia
AGECAT, Automated Geriatric Examination for Computer Assisted Taxonomy; BMI, body mass index; CVS, cardiovascular illnesses variable
incorporating hypertension, diabetes mellitus, ischaemic heart disease, hyperlipidaemia and stroke; DSM, Diagnostic and Statistical Manual of
Mental Disorders; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (IV), Text Revision (TR); ECAQ, Elderly
Cognitive Assessment Questionnaire; EDQ, Early Dementia Questionnaire; GSM, Geriatric Mental State Examination; ICD, International
Classification of Diseases; MCI, Mild Cognitive Impairment; MMSE, Mini Mental State Examination.
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Questionnaire (ECAQ), has been found to range from
2.5% to 36% (table 1).
Risk factors for cognitive impairment have included
age, sex, educational attainment and ethnicity.5 6 8 9 12
However, the link between health and cognition has
been poorly explored in the community-based settings.
Results from studies that have explored health cognition
associations have been mixed including no association
between body mass index or hypertension and cognitive
impairment12 or dementia,9 an association between
dementia and occupational pesticide exposure and
history of stroke in a outpatients setting.10 In a commu-
nity sample, cognitive impairment was not found to be
associated with hypertension,7 while in another study
dementia was found to be associated with cardiovascular
illnesses defined as a combination variable including
hypertension, diabetes mellitus, ischaemic heart disease,
hyperlipidaemia and stroke.15 A more in-depth investiga-
tion of cardiovascular and metabolic risk factors in add-
ition to assessment of other health and lifestyle factors,
which are known risks for dementia; needs to be under-
taken in the Malaysian population.
The main difficulties in conducting dementia studies
in Malaysia have been limitations in assessment methods
including a lack of availability of translations of com-
monly used cognitive screening tests, lack of normative
data, literacy/educational attainment biases and lack of
tests that are sensitive to ethnic differences (Malays,
Chinese and Indians). This project will redress these
through the development and piloting of a neuro-
psychological battery incorporating various cognitive
assessment tools that have been validated in similar
settings.
Knowing the burden of cognitive impairment and
dementia and their risk factors in Malaysia will be neces-
sary for the development of treatment and prevention
strategies and to inform public health policies focused
on an ageing population. Therefore, the objective of
this study is to evaluate the feasibility of detailed cogni-
tive and health assessment using a set of cognitive
battery specifically designed to assess cognition in
Malaysia. The long-term aim is to develop a comprehen-
sive epidemiological research platform for investigating
cognition and dementia in Malaysia, and, thereby, maxi-
mise the number of years free of cognitive impairment
and dementia. This research platform will then provide
a unique resource for studying ageing during economic
transition and across ethnic and religiously diverse
groups.
Objectives
▸ To assess the feasibility and acceptability of a
tablet-based neuropsychological battery, to screen for
cognitive impairment and dementia in individuals
aged 50 years and over within a health and demo-
graphic surveillance site in Malaysia.
▸ To assess the feasibility and acceptability of collecting
physical measurements including gait speed, hand
grip strength, single lead ECG and dried blood spots
(DBS).
▸ To assess the feasibility of establishing an ageing
cohort in order to monitor incidence of dementia,
cognitive decline and other ageing-related health
risks.
METHODS AND ANALYSIS
Participants
This study is embedded within the South East Asia
Community Observatory (SEACO) population.16 SEACO
is a health and demographic surveillance site (HDSS); a
unique research platform in population health and well-
being focused on a middle-income community in
Segamat, Johor in the southern tip of the Peninsular
Malaysia. The district of Segamat comprises urban, rural
and plantation areas with an ethnic mix including
Malays, Chinese and Indian, close to national propor-
tions. SEACO runs its HDSS research platform in five
subdistricts (mukims) of the Segamat district: Bekok,
Chaah, Gemereh, Jabi and Sungai Segamat. In total,
38 228 individuals completed the baseline census
(March 2012 to February 2013) that included informa-
tion on sociodemographic status and self-reported
health conditions. Data were collected by trained inter-
viewers at the person’s place of residence. Individuals
have been reseen after a year (August 2013 to June
2014) for the health round, which collected a detailed
health profile of all the consenting participants.
Individuals aged 50 years and over, who are living in
Segamat Johor and have been assessed as part of SEACO
in its previous health round form the study population.
Nearly 9000 individuals meet these inclusion criteria.
Baseline data from the census, update and health
rounds are used to identify participants for inclusion.
Persons are excluded if they cannot communicate effect-
ively, have severe hearing loss or visual impairment (ie,
are unable to hear normal conversation and/or not able
to see the newsprint), are untraceable or are unable to
give consent. From the eligible population, 200 samples
are selected by stratified random sampling. The target is
to recruit 200 participants stratified by age (50–59 and
≥60 years) and gender, with equal numbers in each
group. Participants are also stratified based on their eth-
nicity (Malay, Chinese, Indian and Orang Asli) to ensure
that each group is represented proportionately to the
composition of the elderly population of SEACO as
shown in figure 1. Stratified sampling is used in order,
not to miss any of these strata in the relatively small
sample, so that operational issues across all the groups
are captured. The SEACO health round data base is
used as the sampling frame.
Data collection
A home visit will be conducted to confirm eligibility,
provide an information sheet, discuss any questions and
to make an appointment for data collection. On the
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appointment date informed consent will be obtained.
All interviews will be conducted in Bahasa Malay or
Chinese according to the participant’s choice. All data
are collected on a Tablet (Samsung Galaxy Tab 3 V),
unless otherwise specified. The assessment interview will
take ∼1.5–2 hours to complete. The ordering of the
measures will be standardised for all participants and
will include:
1. Blood pressure (BP): resting BP will be measured in
triplicate using an Omron electronic BP monitor.
Participants will be resting in a seated position for at
least 10 min before the measurement, and the three
measurements will be taken 1 min apart.
2. Anthropometry: height and weight will be measured
with a combined electronic scales and laser height
measurement device. The participant will be barefoot
and wearing light clothing.
3. Neuropsychological battery: the neuropsychological
battery consists of four components:
3.1. Subjective memory compliant: a single item will
ask participants: Do you have problems with
your memory? (Possible answers are: ‘NO’ OR
‘YES’)? If they answer yes they will be asked add-
itional questions about memory loss in the previ-
ous year; and memory in comparison to other
of same age
3.2. Subjective memory symptom from the relative/
caretaker: a close relative/caretaker will be
asked a single question on problems with
memory of the participant in the past year rela-
tive to previous years with possible answers:
‘NO’ OR ‘YES’.
3.3. MMSE: depending on the language chosen for
interview by the respondent, the Malay
(MMSE-7), or Chinese version will be used to
screen for severe cognitive impairment. The
Malay version was validated by Norlinah and col-
leagues among multiethnic elderly attending
two hospitals in Kuala Lumpur.17 The Chinese
version was validated among a Chinese popula-
tion in Singapore.18 Scores range from 0 to 30,
with higher scores indicating better global cog-
nitive functioning.
3.4. Montreal Cognitive Assessment tool (MoCA)
will be used to screen for milder forms of cogni-
tive impairment.19 The Singapore Chinese20 or
Bahasa Malay version21 will be used, based on
the language of interview of the participants.
All the components of cognitive assessment will be
administered using tablet, except MoCA, which will be
administered in paper form. XLS Form will be used to
create the questionnaire on the tablet, and this will be
developed in consultation with the SEACO IT team. All
MMSE questions, the tasks and the images (along with
the rest of the questionnaire) will be incorporated into
the form. Data collector will administer the tool and will
enter the participant responses and scores for each ques-
tion. The form will be programmed to calculate the total
score (out of 30) for the participant once the data col-
lector finishes administering the MMSE. This score will
help the data collector to decide on need for referral.
4. Functional performance: two tests will be used to assess
functional performance including: handgrip strength
assessed in both arms (in duplicate) using a portable
dynamometer; and, gait speed, which measures using
a stop watch, the time it takes a participant to walk
over a 4 m distance at their usual pace. The respond-
ent will be asked to walk a distance of 6 m while the
stop watch recording starts only at the end of the first
1 m and is stopped at the end of fifth meter of walk.
In the field this is done using a foldable custom-made
device colour coded for easy understanding. The par-
ticipant will also be asked about the history of imbal-
ance on walking.
5. Health and lifestyle questionnaire: participants will be
asked to complete a questionnaire including the
following:
▸ Information on self-rated health status: self-rated
health will be measured by the question ‘How would
you rate your current health?’ and the response will
be captured in a five-point Likert scale of very poor,
poor, neither poor nor good, good and very good.
Figure 1 Stratification grid used for selecting the feasibility study samples from the SEACO population. SEACO, South East
Asia Community Observatory.
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▸ Global Activity Limitation Indicator (GALI)22 which
underlies the European Healthy Life Years indicator
includes a single item that asks ‘For the past
6 months at least, to what extent has you been limited
because of a health problem in activities people
usually do?’
▸ Activities of daily living measured using Katz Index of
Activities of Daily Living (adapted version).23
▸ Lifestyle factors including tobacco and alcohol use—
tobacco use: the participant will be asked if he or she
has ever smoked, history of current smoking, age of
initiation, type of tobacco product used, number of
cigarettes smoked and attempts to quit. Alcohol use:
single item asking ‘Have you consumed alcohol in
the past 30 days?’
▸ Self-reported exhaustion—a single item asking ‘Have
you felt that everything you did was an effort/you
could not get going—for at least 3 days during the
last week?’
▸ Level of activity—two items asking: (1) ‘How often in
the last week did you engage in moderate activities
like gardening, cycling or going for a walk?; and (2)
Do you engage in at least 150 min of
moderate-intensity aerobic physical activity through-
out the week?’
▸ A history of diagnosed conditions such as stroke,
ischaemic heart disease, transient ischaemic attack,
heart failure, hypertension, diabetes (type 1 or type
2) and cancer.
▸ Depression Anxiety Stress Scores.24
6. Dry blood spot collection and blood glucose testing: four
drops of blood will be collected on blood spot card
(Whatman 903), under strict aseptic precaution. The
DBS will be packed with desiccant packs and barcode
labelled. The samples will be transferred to a freezer
(−20°C) within a week of collection. The DBS will be
used to determine glycated haemoglobin levels, lipid
profile and C reactive protein levels. A drop of blood
will also collected to check the random blood sugar
using glucometer.
7. Single lead ECG for atrial fibrillation: the AliveCor
Mobile ECG records, displays, stores and transfers
single channel rhythms. It records a 30 s tracing and
gives the diagnosis as normal or possible atrial fibril-
lation. The ECG recording will be validated against a
diagnosis by cardiologist who is blinded to the diag-
nosis given by the app.
Data collector training and supervision
SEACO is an ISO certified research platform for its
operations and hence training and supervision are
carried out in accordance with SEACO’s standard oper-
ating procedures. All data collectors are required to be
fluent in the local language used for interview (Bahasa
Malay or Mandarin) and have at least a working knowl-
edge of English. To ensure data quality and consistency
across interviewers, the field supervisor will undertake
random concurrent supervisory visits to observe practice.
The data collectors will also be periodically observed by
the project leader and the field manager. Based on the
scoring done during these sessions, onsite training or
retaining will be carried out as appropriate.
ETHICS AND DISSEMINATION
The study protocol was approved by Monash University
Human Research Ethic Committee (CF15/4367—
2015001885). Informed consent will be obtained from
all eligible participants through signed or video consent.
Separate consent will be obtained from the relative
before interviewing them on the participants’ cognitive
status. All participants will receive feedback from their
interview which includes information about their height,
weight, BP, MMSE score, glucometer blood sugar level
and ECG diagnosis; with specific mention of the items
that require a physician consultation and evaluation.
The cut-offs used for referrals across the different mea-
sures are shown in table 2. All data and samples col-
lected in the study will be delinked prior to analysis to
ensure that anonymity is maintained.
The project data and findings will be made available
through publications and conference presentations. There
is also a searchable data archive under development that
would ensure data sharing. Reports will be made available
as community briefs on the SEACO website.
DISCUSSION
What is unique about the study?
Malaysian economy is growing and it is predicted that by
2020 Malaysia will transition to becoming a high-income
country. Further, Malaysia is a multiethnic country.
Therefore, the proposed project will provide a unique
resource for studying ageing during economic transition
and across ethnic and religiously diverse groups. Risk
factors and disease associations may not be consistent
with those reported in other world regions where the
focus has been on Caucasian populations in a higher
income context, and with access to higher quality
Table 2 Cut-offs used for referral of participants in the
study across the different measures
Measurements
Cut-off used for referral for
further medical evaluation
BP At least one of the three systolic
BP recording ≥140 mm of Hg
and/or at least one of the three
diastolic BP recording ≥90 mm of
Hg
MMSE score (out of a
total of 30)
≤20
Glucometer random
blood sugar
≥11.1 mmol/L
Single lead ECG
diagnosis
Possible atrial fibrillation
BP, blood pressure; MMSE, Mini Mental State Examination.
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healthcare and state of the art health technologies for
diagnostics and treatment. The study provides the
opportunity to evaluate these in the Malaysian context
which is more typical of countries within the South East
Asian region. The study can also draw on the extensive
sociodemographic and health data infrastructure as well
as access to populations facilitated through the SEACO
community engagement process. This will enhance the
response and retention rates towards the establishment
of a sustained cohort of elderly people for the long-term
assessment of cognitive function in Malaysia.
Why is the study important?
Knowing the burden of cognitive impairment and
dementia and risk factors for disease in Malaysia will be
necessary for the development of treatment and preven-
tion efforts but it is also important to view these along-
side continued increases in life expectancy through
population-level indicators such as healthy life expect-
ancy. A similar non-Caucasian resource is the 10/66
Research Study, a multicountry study that explores
dementia and ageing in low-income and middle-income
countries.25 While there are some data on variability in
dementia prevalence and its risk factors (eg, level of
educational attainment), questions about ethnic and cul-
tural variation remain unanswered. Our study will there-
fore complement and extend the work undertaken by
the10/66 Dementia Research Group. It will also provide
the opportunity to develop a range of cross-culturally
validated tools. The study will provide a comprehensive
epidemiological research platform for investigating cog-
nition and dementia in Malaysia, and, in the longer
term, to maximise the number of years free of cognitive
impairment and dementia.
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